Discover Community Create You

Loading publication...

Noodle always counts identifier-free feature events for service operation. With your permission, Google Analytics can also estimate audience and engagement. Search text, publication identifiers, cookies, IP addresses and browser fingerprints are never included in Noodle's first-party event counters.

Privacy details

Article

Utility of hepatitis C virus RNA levels for predicting the therapeutic efficacy of interferon.

Journal of clinical gastroenterology - 1 Oct 1997

Kato J, Komatsu M, Ono T, Ishii T, Hoshino T, Toyoshima I, Chiba M, Masamune O

Abstract excerpt

We studied the levels of serum hepatitis C virus (HCV)-RNA, the HCV genotype before interferon therapy, and the kinetics of serum HCV-RNA at the initial stages of therapy to determine their utility in predicting the therapeutic efficacy of interferon in 44 patients with chronic hepatitis C infection. We also looked at the efficacy of repeated interferon treatment in relation to the kinetics of serum HCV-RNA. The...

Read the complete abstract on PubMed

Topics

Share this publication in a Topic to start or enrich a Post.

Share to Aged
Share to Alanine Transaminase
Share to Genotype

Methodology Data sources Editorial policy Privacy Delete account & data About Contact Helena Bioinformatics

Share to Hepacivirus

Share to Hepatitis C

Share to Prognosis

Share to RNA, Viral

Share to Treatment Outcome

Source

Identifiers

PMID: 9412970
DOI: 10.1097/00004836-199710000-00009

Provenance

PubMed metadata and Literature Corpus relationships. Corpus snapshot updated 7 Sept 2026. Manifest publication-graph-cohort-2026-09-08.1.

Source receipt: pubmed, retrieved 7 Sept 2026.

Related research

Semantic proximity does not establish scientific evidence. Graph snapshot: 2026-09-29.

Research trail→

Click a neighbor to travelStep 1 · 12 closest

Utility of hepatitis C virus RNA levels for predicting the therapeutic efficacy of interferon.PMID 9412970Read ↗

Pretreatment serum hepatitis C virus RNA levels and hepatitis C virus genotype are the main and independent prognostic factors of sustained response to interferon alfa therapy in chronic hepatitis C.Semantic proximity Read ↗

Pretreatment viral load and response to prolonged interferon-alpha course for chronic hepatitis C.Semantic proximity Read ↗

Serum HCV RNA titer at the end of interferon therapy predicts the long-term outcome of treatment.Semantic proximity Read ↗

Dynamics of hepatitis C virus monitored by real-time quantitative polymerase chain reaction during first 2 weeks of IFN-beta treatment are predictive of long-term therapeutic response.Semantic proximity Read ↗

Comparison of HCV RNA levels by branched DNA probe assay and by competitive polymerase chain reaction to predict effectiveness of interferon treatment for patients with chronic hepatitis C virus.Semantic proximity Read ↗

Predicting response to initial therapy with interferon plus ribavirin in chronic hepatitis C using serum HCV RNA results during therapy.Semantic proximity Read ↗

Transient reappearance of serum hepatitis C virus RNA observed by real-time PCR during antiviral therapy with peginterferon and ribavirin in patients with HCV genotype 1b.Semantic proximity Read ↗

Changes in serum hepatitis C virus RNA titer and response to interferon therapy in patients with chronic hepatitis C.Semantic proximity Read ↗

Predicting interferon therapy efficacy from hepatitis C virus genotype and RNA titer.Semantic proximity Read ↗

Serum hepatitis C virus RNA levels in chronic hepatitis C--importance for outcome of interferon alfa-2b treatment.Semantic proximity Read ↗

Decrease of HCVRNA after three days of daily interferon treatment is predictive of the virological response at one month.Semantic proximity Read ↗

Monitoring virological responses to interferon-ribavirin and interferon monotherapy of chronic hepatitis C re-treated due to relapse or non-response.Semantic proximity Read ↗

⌁Select a neighboring publication to make it the new centre.